Probiodrug AG announced that Dr. Michael Schaeffer has been appointed to the position of Executive Vice President of Business and Strategy, effective August 2018. He brings more than 15 years of experience across pharma and biotech in strategic business development, scientific project and alliance management to the company. Prior to joining the company, he was the Founder and Managing Director of biotech companies, CRELUX GmbH and SiREEN AG. Under his leadership CRELUX nearly doubled its revenues within one year. Following the acquisition of CRELUX by WuXiAppTec in 2016, he was responsible for integrating CRELUX into the leading global CRO with over 18,000 employees based in Shanghai.